Back

Inflammatory Stromal Aging in Ulcerative Colitis and Colitis-Associated Cancer

Almotah, K.; Tran, U.; Schweickart, R. A.; Gilbert, H.; Fisher, R. C.; Bisikalo, Y.; Ali, M.; Buhaya, M.; Cheng, M.; Cruise, M.; Chi, Z.; Sarvestani, S. K.; Huang, E. H.; Wessely, O.

2026-05-20 cancer biology
10.64898/2026.05.18.725891 bioRxiv
Show abstract

ABSTRACTUlcerative colitis is a chronic inflammatory bowel disease that can progress from dysplasia to cancer. Inflammatory responses are critical drivers in this process, typically triggered by epithelial lesions and the ensuing infiltration of microbiota into the interstitial layer. Here, we focus on the pro-inflammatory state of the interstitial fibroblasts, which promotes immune infiltration and augments disease progression. The study aims to provide a mechanistic link how fibroblasts of the colitis-associated microenvironment integrate inflammatory signals, microbial infiltration and cellular memory. To this end, we investigated a large number of primary colon fibroblasts obtained from normal, colitis and colon cancer samples using a range of in vitro approaches and an in vivo co-inoculation cancer model. mRNA sequencing analysis identified that the disease-associated fibroblasts are exhibit a cellular inflammatory status, which involves the injury-induced senescence pathway. Using CXCL8, a potent chemokine upregulated in colitis and cancer colon fibroblasts, as a paradigm, this inflammatory status is triggered by the activation of the NF{kappa}B signaling via immune-derived cytokines (TNF, IL-1{beta}), bacterial signals (LPS) and the microbiome itself using mycoplasma as a paradigm. Finally, iPSC reprogramming studies indicate that fibroblasts from ulcerative colitis retain an epigenetic memory that sustains elevated CXCL8 expression. Together, our findings demonstrate that the senescence associated secretory phenotype of colon fibroblasts is a robust indicator for inflammation-driven colon tumorigenesis.

Matching journals

The top 14 journals account for 50% of the predicted probability mass.

1
The Journals of Gerontology: Series A
25 papers in training set
Top 0.1%
10.6%
2
Cell Reports
1338 papers in training set
Top 7%
6.4%
3
Aging
69 papers in training set
Top 0.4%
4.9%
4
Scientific Reports
3102 papers in training set
Top 27%
4.4%
5
Clinical Epigenetics
53 papers in training set
Top 0.2%
4.4%
6
JCI Insight
241 papers in training set
Top 2%
3.1%
7
iScience
1063 papers in training set
Top 8%
2.6%
8
International Journal of Molecular Sciences
453 papers in training set
Top 4%
2.4%
9
Cancers
200 papers in training set
Top 2%
2.1%
10
PLOS ONE
4510 papers in training set
Top 47%
2.1%
11
Gastroenterology
40 papers in training set
Top 0.9%
1.9%
12
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.3%
1.9%
13
Computational and Structural Biotechnology Journal
216 papers in training set
Top 4%
1.7%
14
Cell Communication and Signaling
35 papers in training set
Top 0.4%
1.7%
50% of probability mass above
15
Cell Reports Medicine
140 papers in training set
Top 4%
1.7%
16
Nature Communications
4913 papers in training set
Top 51%
1.7%
17
npj Biofilms and Microbiomes
56 papers in training set
Top 1%
1.7%
18
Molecular Oncology
50 papers in training set
Top 0.4%
1.5%
19
Frontiers in Immunology
586 papers in training set
Top 5%
1.3%
20
eLife
5422 papers in training set
Top 47%
1.3%
21
Cells
232 papers in training set
Top 4%
1.2%
22
Frontiers in Oncology
95 papers in training set
Top 3%
1.2%
23
PLOS Biology
408 papers in training set
Top 13%
1.2%
24
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 41%
0.9%
25
mBio
750 papers in training set
Top 10%
0.9%
26
Disease Models & Mechanisms
119 papers in training set
Top 2%
0.9%
27
PLOS Genetics
756 papers in training set
Top 13%
0.9%
28
The FASEB Journal
175 papers in training set
Top 2%
0.9%
29
Redox Biology
64 papers in training set
Top 0.8%
0.8%
30
BMC Medicine
163 papers in training set
Top 6%
0.8%